The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore

SY Lim, SM Davidson, MM Mocanu, DM Yellon… - … drugs and therapy, 2007 - Springer
SY Lim, SM Davidson, MM Mocanu, DM Yellon, CCT Smith
Cardiovascular drugs and therapy, 2007Springer
Abstract Background Necrostatin (Nec-1) protects against ischemia–reperfusion (IR) injury
in both brain and heart. We have previously reported in this journal that necrostatin can
delay opening of the mitochondrial permeability transition pore (MPTP) in isolated
cardiomyocytes. Aim The aim of the present study was to investigate in more detail the role
played by the MPTP in necrostatin-mediated cardioprotection employing mice lacking a key
component of the MPTP, namely cyclophilin-D. Method Anaesthetized wild type (WT) and …
Background
Necrostatin (Nec-1) protects against ischemia–reperfusion (IR) injury in both brain and heart. We have previously reported in this journal that necrostatin can delay opening of the mitochondrial permeability transition pore (MPTP) in isolated cardiomyocytes.
Aim
The aim of the present study was to investigate in more detail the role played by the MPTP in necrostatin-mediated cardioprotection employing mice lacking a key component of the MPTP, namely cyclophilin-D.
Method
Anaesthetized wild type (WT) and cyclophilin-D knockout (Cyp-D−/−) mice underwent an open-chest procedure involving 30 min of myocardial ischemia and 2 h of reperfusion, with subsequent infarct size assessed by triphenyltetrazolium staining. Nec-1, given at reperfusion, significantly limited infarct size in WT mice (17.7 ± 3% vs. 54.3 ± 3%, P < 0.05) but not in Cyp-D−/− mice (28.3 ± 7% vs. 30.8 ± 6%, P > 0.05).
Conclusion
The data obtained in Cyp-D−/− mice provide further evidence that Nec-1 protects against myocardial IR injury by modulating MPTP opening at reperfusion.
Springer